Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- donanemab
- Pletal (cilostazol)
Interactions between your drugs
cilostazol donanemab
Applies to: Pletal (cilostazol), donanemab
Using donanemab together with blood-thinning or clot-dissolving medications has not been adequately studied. There are some theoretical concerns that combining donanemab and cilostazol may increase the risk of bleeding in the brain. Talk to your doctor if you have any questions or concerns. Your doctor will do magnetic resonance imaging (MRI) scans before and during your treatment with donanemab as part of monitoring for potential side effects in the brain. You should seek immediate medical attention if you experience signs and symptoms that may suggest more serious treatment complications such as headache, confusion, dizziness, vision changes, nausea, difficulty walking, or seizures. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
cilostazol food
Applies to: Pletal (cilostazol)
Take cilostazol on an empty stomach 1 hour before or 2 hours after a meal unless otherwise directed by your doctor. Food may reduce the absorption of cilostazol. Taking cilostazol on an empty stomach will make it easier for your body to absorb the medication. If you are receiving therapy with cilostazol you should avoid grapefruits and grapefruit juice. Grapefruit can raise the levels of cilostazol in your body and lead to dangerous side effects. You may experience headache, dizziness, chest pain, feeling short of breath, and swelling of your ankles or feet. Call your doctor at once if you have any of these symptoms.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Aricept
Aricept is used to treat mild to severe dementia caused by Alzheimer's disease. Learn about side ...
Namenda
Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Leqembi
Leqembi (lecanemab) is used to treat Alzheimer’s disease to help slow the progression of dementia s ...
Namzaric
Namzaric (memantine/donepezil) is used to treat Alzheimer's Disease. Includes Namzaric side ...
Kisunla
Kisunla (donanemab) is used to treat Alzheimer’s disease to help slow down the decline in memory, t ...
Razadyne
Razadyne information from Drugs.com, includes Razadyne side effects, interactions and indications.
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.